Evidence map›Paper›PMID 36627305›Full record

ArticleScientific data2023

InvitroSPI and a large database of proteasome-generated spliced and non-spliced peptides.

Hanna P Roetschke, Guillermo Rodriguez-Hernandez, John A Cormican, Xiaoping Yang, Steven Lynham, Michele Mishto, Juliane Liepe

Open access · goldAbstract readDataset
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific data, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Hanna P RoetschkeMax-Planck-Institute for Multidisciplinary Sciences (MPI-NAT), 37077, Göttingen, Germany.ORCID 0000-0001-7272-6677
Guillermo Rodriguez-HernandezCentre for Inflammation Biology and Cancer Immunology (CIBCI) & Peter Gorer Department of Immunobiology, King's College London (KCL), SE1 1UL, London, UK.
John A CormicanMax-Planck-Institute for Multidisciplinary Sciences (MPI-NAT), 37077, Göttingen, Germany.
Xiaoping YangProteomics Core Facility, James Black Centre, King's College London (KCL), SE5 9NU, London, UK.
Steven LynhamProteomics Core Facility, James Black Centre, King's College London (KCL), SE5 9NU, London, UK.
Michele MishtoCentre for Inflammation Biology and Cancer Immunology (CIBCI) & Peter Gorer Department of Immunobiology, King's College London (KCL), SE1 1UL, London, UK. michele.mishto@kcl.ac.uk.ORCID 0000-0003-3042-2792
Juliane LiepeMax-Planck-Institute for Multidisciplinary Sciences (MPI-NAT), 37077, Göttingen, Germany. jliepe@mpinat.mpg.de.
King's College London · GBMax Planck Institute for Multidisciplinary SciencesMax Planck Institute for the Study of Religious and Ethnic Diversity · DE

Funding

Cancer Research UK 29686Wellcome Trust
6 · The paper itself

Abstract

Noncanonical epitopes presented by Human Leucocyte Antigen class I (HLA-I) complexes to CD8

Indexed as

CD8-Positive T-LymphocytesProteasome Endopeptidase ComplexCytoplasmHistocompatibility Antigens Class IHumansPeptidesHistocompatibility Antigens Class IPeptidesProteasome Endopeptidase Complex

Identifiers

PMID36627305
PMCPMC9832164
OpenAlexW4315481706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.